Pharma’s Digital Media Adoption Curve: The Timing is Right for Innovators to “Hook Up”...
The Pharma Digital Media Adoption Curve illustrates how the drug industry is overcoming the regulatory hurdles to adopting emerging digital technology and especially social media.
Fans & Bananas: Viagra Ads in Japan
Hat tip to my friend @blogaceutics (Miguel Tovar) who tweeted about a "novel twist" on Viagra advertising in Japan: paper fans that promote Viagra...
Pharma’s Social Media Influence Measures Faulted
Andrew Spong, author of STweM blog across the pond in the UK, doesn't like the way pharmaceutical companies and their agencies measure social media...
GSK, GSK, GSK: TSK, TSK, TSK!
Revelations about the China bribery scandal involving GlaxoSmithKline (GSK) continue to emerge in the media and each day brings new shockers. A story in...
Bad GSK in China –> Lower Drug Prices for Patients. Bad GSK in U.S....
"Savings made as a result of proposed changes to our operational model will be passed on in the form of price reductions (my emphasis), ensuring...
Pharma Seeks Digital Innovators: A New Phase of the “Pharma Digital Hype Cycle”
The pharmaceutical industry has often been criticized for being behind the "digital curve," meaning that it lacks the expertise to fully take advantage of...
#Pharma100: A Ludicrous, Leveraged Popularity Contest
"Stop using #pharma100," says Andrew Spong. Spong says it's "a ludicrous popularity contest... that degrades the health conversation on the Social Web." Quite a...
AZPurpleZone: A Nexium Branded YouTube Channel. “Unusual” for Pharma? Yes. “Engaging Social Media?” No!
"AstraZeneca believes that it is important to share information with patients by engaging with them online," says Ken Graham, Commercial Business Leader, GI, AstraZeneca,...
The MeltDown of Paula Deen Continues
Just when you thought the latest Paula Deen news cycle is over, up pops a new article about the celebrity chef's fall from grace.
For...
FDA is Lax in Enforcing Law Regarding Prescription Drug Postmarketing Studies
The Food and Drug Administration Amendments Act (FDAAA), passed by Congress in 2007, authorized the FDA to require postmarketing studies for a prescription drug’s...
